PharmacoEconomics & Outcomes News 804, p38 - 2 Jun 2018 PHARMAC seeking consumer input on funding decisions New Zealand’s Pharmaceutical Management Agency, PHARMAC, is seeking consumer input on funding decisions. The agency is reviewing the way the consumer’s viewpoint is incorporated into decisions, and asking how it can improve feedback from the public. "Feedback from New Zealanders who receive – or could receive – funded medicines or medical devices is important to us," said Sarah Fitt, PHARMAC Chief Executive, "We’re always looking to improve how we make decisions, this includes how we seek and use consumer views in our work. We want to know if the way we do this now is working, and if not, how we can improve." PHARMAC staff are holding community conversations at five locations in New Zealand during May and June 2018, and will also gather feedback via a discussion document and online survey which close on 6 July 2018. "We hope that people take this opportunity to help us make improvements to the way we engage with consumers, and incorporate New Zealanders’ voices into our work," said Ms Fitt. PHARMAC. Community voices important to PHARMAC. Internet Document : 25 May 2018. Available from: URL: https://www.pharmac.govt.nz/news/ media-2018-05-28-consumer-voice-important-to-pharmac/ 803324248 1173-5503/18/0804-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Jun 2018 No. 804
PharmacoEconomics & Outcomes News – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera